List of reimbursed medicinal products valid as of 1.8.2012

Acting in compliance with Section 39n(1) of Act No. 48/1997 Coll., on Public Health Insurance, as amended (“Act”), the State Institute for Drug Control publishes the List of Prices and Reimbursements for Medicinal Products and Foods for Special Medicinal Purposes (“List”) in a new data interface version that reflects the changes ensuing from Act No. 298/2011 Coll. In light of the foregoing, ordinary updates of the List will no longer be published.    

Acting in compliance with Section 39n(1) of Act No. 48/1997 Coll., on Public Health Insurance, as amended (“Act”), the State Institute for Drug Control publishes the List of Prices and Reimbursements for Medicinal Products and Foods for Special Medicinal Purposes Covered by the Public Health Insurance Scheme (“List”). The List, published on the 1stday of the calendar month, includes a full list of medicinal products (MPs) and foods for special medicinal purposes (FSMPs) covered by the public health insurance scheme that are reimbursed by decision of the Institute, including the maximum or announced ex-factory prices, the amount and terms of reimbursement, incl. the maximum possible reimbursement for the end consumer, and the supplementary payment in the eligible limit.

In addition, the List contains basic reimbursements of reference groups, explaining how the basic reimbursements were set, along with a full list of medicinal products and foods for special medical purposes classified in the reference groups, and the maximum prices of medicinal products and foods for special medical purposes where the Institute has the power to make decisions on the maximum price, and a full list of medicinal products and foods for special medical purposes with an explanation how the maximum prices were set. 

On 27 July 2012, the judgment of the Supreme Administrative Court in the legal case brought by the Petitioner, Zentiva a.s., ID No. (IČ) 31411771, having its registered office at Nitranská 100, Hlohovec, Slovak Republic, against the Defendant, Ministry of Health of the Czech Republic, with seat at Palackého náměstí 4, Prague 2, against the Defendant’s 13 April 2010 decision, ref. no. MZDR 5232/2010, file no. FAR:L19/2010, in the proceedings on the Defendant’s cassation complaint against the 12 April 2012 decision of the Municipal Court in Prague, ref. no. 11 Ad 13/2010 – 104, has become effective, whereby the Supreme Administrative Court cancelled the judgment of the Municipal Court and remanded the matter for further proceedings.

The foregoing has been reflected in the List issued by the Institute under the provision of Section 39n(1) of Act No. 48/1997 Coll., on Public Health Insurance and on Amendments to Some Related Acts. 

List of prices of medicinal products and f used in institutional care only